The Canadian government has recently approved patients with life-threatening mental illnesses to be treated with MDMA and psilocybin.
Psilocybin is the active psychedelic chemical found in some species of mushrooms. Given its natural development, many countries including Canada have been testing the chemical for medical benefits for many years now.
In the United States, citizens of the state of Oregon voted in a ballot measure that made psilocybin a legal medical treatment back in 2020. Last year, California got one step closer to decriminalizing psilocybin as well. The new measure in Canada extends legality throughout the entire country.
Patients in Canada will be able to access the restricted drugs through what’s known as the Special Access Program. This program exists for patients who can not receive traditional therapy.
“There has been emerging scientific evidence supporting potential therapeutic uses for some restricted drugs, most notably psychedelic restricted drugs such as MDMA and psilocybin,” the Canadian Government’s official communication stated.
Click here for more information on the treatments and how patients can access them.
Featured image by Getty Images
